Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
40%
OVERLAP
BY WEIGHT
13
# OF OVERLAPPING
HOLDINGS
PBPH
57
HOLDINGS
25%
ALSO IN PJP
PJP
31
HOLDINGS
48%
ALSO IN PBPH
SECTOR DRIFT (PBPH minus PJP)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PBPH |
Weight in PJP |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 16.9% | 6.1% | 6.1% |
|
ABBVIE INC | 7.4% | 5.9% | 5.9% |
|
JOHNSON & JOHNSON | 9.3% | 5.3% | 5.3% |
|
MERCK & CO. INC. | 5.2% | 5.1% | 5.1% |
|
AMGEN INC | 4.4% | 5.6% | 4.4% |
PBPH Overweight Relative to PJP
|
ELI LILLY & CO | 10.8% |
 |
ASTRAZENECA PLC | 4.8% |
 |
NOVARTIS AG | 4.2% |
|
JOHNSON & JOHNSON | 4.0% |
|
VERTEX PHARMACEUTICALS INC | 2.7% |
 |
NOVO NORDISK A/S-B | 2.5% |
 |
SANOFI-AVENTIS | 1.9% |
|
GSK PLC | 1.8% |
|
MODERNA, INC. | 1.5% |
|
ABBVIE INC | 1.5% |
PBPH Underweight Relative to PJP
|
ABBOTT LABORATORIES | -4.9% |
|
AMNEAL PHARMACEUTICALS, INC. CLASS A | -3.6% |
|
LIGAND PHARMACEUTICALS-CL B | -3.5% |
 |
PERRIGO CO | -3.3% |
|
TARSUS PHARMACEUTICALS, INC. | -3.2% |
|
INNOVIVA, INC. | -3.0% |
|
VIATRIS, INC. | -3.0% |
|
HARMONY BIOSCIENCES HOLDINGS, INC. | -3.0% |
|
UNITED THERAPEUTICS CORP | -3.0% |
|
BIOSANTE PHARMACEUTICALS INC | -2.9% |